News
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
TBC
Generic name
cabotegravir/rilpivirine
Manufacturer
ViiV Healthcare ULC
Indication(s)
HIV-1 infection
Project Number
SR0628-000
Call for patient input
2019-07-19
Patient input d...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
ustekinumab
Generic name
Stelara
Manufacturer
Janssen Inc.
Indication(s)
Ulcerative colitis
Project Number
SR0627-000
Call for patient input
2019-07-12
Patient input deadline
2...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
Ottawa, ON (July 10, 2019) — Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new Patient and Community Advisory Committee.
Twelve individuals from across the country have been invited to join the committee as inaugural members. Committee members are patients or family caregivers and reflect the di...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
TBC
Generic name
glucagon
Manufacturer
Eli Lilly Canada Inc.
Indication(s)
Severe hypoglycemic reactions
Project Number
SR0626-000
Call for patient input
2019-06-25
Patient input d...
